What Hyperbaric Oxygen Therapy Is
Hyperbaric oxygen therapy (HBOT) is a medical treatment in which you breathe pure oxygen inside a pressurized chamber. The pressure is typically two to three times higher than normal air pressure. This increased pressure allows your lungs to absorb more oxygen than they would at sea level, and your blood carries that extra oxygen throughout your body.
A typical HBOT session lasts 60 to 120 minutes. You sit or lie in a clear acrylic chamber — either alone in a monoplace chamber or with others in a multiplace chamber where oxygen is delivered through a mask or hood. Most treatment plans involve 20 to 40 sessions spread over several weeks. The therapy has been used in hospitals for decades, originally to treat decompression sickness (the "bends") in divers.
Key Takeaways
- HBOT increases the amount of oxygen your blood can carry by pressurizing a chamber around you, but the body's ability to use extra oxygen varies by condition.
- Strong evidence supports HBOT for diabetic foot ulcers, certain wound infections, and decompression sickness; evidence is weaker or mixed for other conditions.
- The therapy is FDA-approved for 14 specific conditions, though doctors sometimes use it off-label for conditions with less established benefit.
- Sessions are generally safe but carry small risks including ear barotrauma, sinus pressure, and in rare cases, oxygen toxicity or lung collapse.
- Insurance coverage depends on the condition being treated and whether it matches FDA-approved uses; many off-label uses are not covered.
The Mechanism: How Oxygen Reaches Tissues
At sea level, oxygen travels in your blood in two ways: bound to hemoglobin (the protein in red blood cells) and dissolved directly in the blood plasma. Hemoglobin is nearly saturated with oxygen under normal conditions, so increasing air pressure does not significantly increase hemoglobin-bound oxygen. The real gain comes from dissolved oxygen.
Under pressure, more oxygen dissolves into your blood plasma — the liquid part of blood. This dissolved oxygen can reach tissues that have poor blood flow or are starved of oxygen. The theory behind HBOT is that tissues with inadequate oxygen (hypoxic tissues) can heal better when oxygen levels rise. For some wounds and infections, this mechanism has been proven to work. For others, the benefit remains unclear or unproven.
FDA-Approved Uses With Established Evidence
The FDA has approved HBOT for 14 specific conditions. The strongest evidence exists for diabetic foot ulcers — multiple randomized controlled trials show that HBOT combined with standard wound care reduces the risk of amputation. The therapy is also well-supported for acute traumatic wounds, certain bone infections (osteomyelitis), and radiation-induced tissue damage in cancer survivors.
Decompression sickness and arterial gas embolism (air bubbles in blood vessels) have the longest track record; HBOT is the standard treatment for these diving-related emergencies. Chronic wounds from burns, grafts, and flaps also show consistent benefit in the research. These uses represent the clearest cases where increased oxygen delivery directly addresses the underlying problem.
Conditions With Mixed or Emerging Evidence
HBOT is sometimes used for conditions where the evidence is less clear. Chronic fatigue syndrome, fibromyalgia, and autism have been studied in small trials with mixed results — some show modest improvement, others show no difference from placebo. A 2022 trial in JAMA found no benefit for chronic fatigue, while earlier smaller studies suggested some patients improved. The picture remains inconsistent.
Stroke recovery, traumatic brain injury, and multiple sclerosis have been investigated because oxygen deprivation plays a role in these conditions. However, large randomized trials have not shown clear benefit, and professional organizations do not recommend HBOT as standard treatment. Some patients report subjective improvement, but this may reflect placebo effect or natural recovery over time rather than the therapy itself.
Lyme disease, cancer treatment, and "anti-aging" are promoted by some clinics but lack rigorous evidence. The American Medical Association and most medical societies do not support these uses. Insurance will not cover HBOT for these indications, and the out-of-pocket cost — typically $150 to $300 per session — can add up quickly.
What the Research Actually Shows
The quality of evidence varies widely. For diabetic foot ulcers, the evidence comes from multiple randomized controlled trials (the gold standard) involving hundreds of patients. For conditions like fibromyalgia, the evidence comes from small, short-term studies that are harder to interpret. Some trials have methodological weaknesses — for example, it is difficult to truly blind patients to HBOT since they can feel the pressure change.
Observational studies (where researchers track outcomes without randomly assigning people to treatment) show associations but cannot prove cause and effect. A patient who improves after HBOT may have improved anyway, or may have also changed diet, exercise, or other treatments at the same time. The stronger the study design, the more confident we can be in the result.
Side Effects and Safety Considerations
HBOT is generally well-tolerated, but side effects do occur. The most common is barotrauma — pressure-related injury to the ear or sinuses. This happens when pressure inside the chamber increases faster than you can equalize the pressure in your middle ear. Most people learn to equalize by swallowing or using the Valsalva maneuver (pinching your nose and gently blowing). Severe ear barotrauma is rare with proper technique.
Temporary vision changes (myopia or nearsightedness) can develop during a course of treatment and usually reverse after therapy ends. Oxygen toxicity — poisoning from breathing too much oxygen — is rare at the pressures used in HBOT but can cause seizures or lung collapse if it occurs. Claustrophobia is a practical concern; some people cannot tolerate being in the chamber. Infection at the site of an IV line (if one is placed) is possible but uncommon.
HBOT should not be used if you have untreated pneumothorax (collapsed lung) or are taking the drug cisplatin (a chemotherapy agent), as the combination increases risk. People with fever, upper respiratory infections, or uncontrolled diabetes may be advised to postpone treatment.
Cost and Insurance Coverage
The cost of HBOT varies by location and facility. A single session typically costs $150 to $300. A full course of 30 to 40 sessions can total $4,500 to $12,000 or more. Some facilities offer package discounts. Insurance coverage depends on the diagnosis and whether it matches an FDA-approved use. Medicare covers HBOT for the 14 FDA-approved conditions when ordered by a physician. Private insurance policies vary; some follow Medicare's list, others have their own criteria.
For off-label uses — conditions not on the FDA list — insurance rarely covers the cost, and you would pay out of pocket. Before starting treatment, ask the clinic whether your insurance will cover it and get a written estimate of total cost. Some clinics offer payment plans.
Frequently Asked Questions
Is HBOT the same as using an oxygen tank at home?
No. Home oxygen therapy delivers oxygen at normal air pressure through a mask or nasal cannula. HBOT uses a pressurized chamber, which is what allows extra oxygen to dissolve into your blood. The pressure is essential to the mechanism; oxygen alone at normal pressure would not produce the same effect.
Can HBOT cure autism or chronic fatigue?
The evidence does not support HBOT as a cure for either condition. Small studies have shown mixed results, and large rigorous trials have not found clear benefit. Some people report feeling better, but this may be due to placebo effect or other changes happening at the same time. Talk to your doctor about whether a trial might be worth considering in your specific situation.
How long does it take to feel results?
For diabetic foot ulcers and other FDA-approved uses, improvement typically develops over weeks as the course of treatment progresses. For other conditions, the timeline is less clear. Some people report changes within a few sessions; others see no change after a full course. If you have not noticed improvement after 20 sessions, further sessions are unlikely to help.
What happens if I stop treatment early?
Stopping early means you do not complete the planned course. For conditions like diabetic ulcers, completing the full course is associated with better outcomes. If you are experiencing side effects or cannot tolerate the chamber, talk to your doctor about whether a modified schedule or a different treatment might work better.
Does HBOT work for wound healing in general?
It depends on the type of wound. HBOT is proven effective for diabetic foot ulcers and certain chronic wounds. For acute injuries or surgical wounds in people without diabetes, the evidence is weaker. Your doctor can advise whether HBOT is likely to help your specific wound based on its cause and how it is healing.